Adjuvant docetaxel and cyclophosphamide plus trastuzumab in patients with HER2-amplified early stage breast cancer: a single-group, open-label, phase 2 study
| Autor: | Jones, Stephen E, Collea, Rufus, Paul, Devchand, Sedlacek, Scot, Favret, Anne M, Gore, Ira, Jr, Lindquist, Deborah L, Holmes, Frankie Ann, Allison, Mary Ann K, Brooks, Barry D, Portillo, Raul M, Vukelja, Svetislava J, Steinberg, Michael S, Stokoe, Christopher, Crockett, Maria W, Wang, Yunfei, Asmar, Lina, Robert, Nicholas J, O'Shaughnessy, Joyce |
|---|---|
| Zdroj: | In The Lancet Oncology October 2013 14(11):1121-1128 |
| Databáze: | ScienceDirect |
| Externí odkaz: |
|